Acute abdomen in a patient with homozygous type I hereditary angioedema: rapid improvement in computed tomography scans after C1 inhibitor replacement.
نویسندگان
چکیده
Hereditary angioedema (HAE) due to C1-inhibitor de ciency is a rare autosomal dominant disease characterized by recurrent episodes of transient localized swelling of the subcutaneous and/or mucosal tissues that can occur anywhere in the body. Acute abdominal pain due to mucosal swelling of the gut is one of the most common presentations of HAE, leading frequently to unnecessary abdominal surgery such as exploratory laparotomy and appendectomy. We report the case of a patient with a previous diagnosis of HAE who experienced an episode of severe acute abdominal pain with striking computed tomography (CT) ndings that resolved rapidly after intravenous infusion of a C1 esterase inhibitor (C1-INH) concentrate and no other therapy. The patient had type I HAE in homozygosis, ie, a mutation affecting the coding region of C1INH in both alleles, which is extremely rare. His only treatment was low-molecular-weight heparin injections for acute angioedema attacks. The patient was a 22-year-old man who presented at the emergency department with diffuse abdominal pain that had begun the previous day. He had no other gastrointestinal or general symptoms. He had a history of HAE with a speci c familial homozygous mutation in the C1INH gene, which was the subject a previous publication by our group [1] and a detailed editorial comment [2]. The patient was allergic to nuts and rosaceae and smoked 10 cigarettes a day. Initially, he received therapy with stanozolol (2-4 mg/d) for several months, although this was withdrawn because of undesirable androgenic effects (including alopecia) and a poor response Figure. Abdominopelvic computed tomography scan before and after intravenous infusion of C1-INH. Coronal reconstruction. A, Diffuse hypodense thickening of the ascending colon and ileocecal region before therapy. B, Thickening of the transverse colon before therapy. C and D, Marked reduction in infl ammatory swelling of the transverse colon, ascending colon, and cecum 12 hours after intravenous infusion of C1-INH. A B
منابع مشابه
Refractory Angioedema in a Patient with Systemic Lupus Erythematosus
Angioedema secondary to C1 inhibitor deficiency has been rarely reported to be associated with systemic lupus erythematosus. A genetic defect of C1 inhibitor produces hereditary angioedema, which is usually presented with cutaneous painless edema, but edema of the genital area, gastrointestinal and laryngeal tracts have also been reported.In lupus patients, angioedema may be the result of an ac...
متن کاملReport on the First Survey of Iranian Patients with Hereditary Angioedema
Background: Hereditary angioedema (HAE) is a rare autosomal dominant primary immunodeficiency with complement system defect characterized by recurrent episodes of angioedema involving the skin or mucosa of the upper respiratory and gastrointestinal tracts. Objective: To characterize the clinical and laboratory data of hereditary angioedema in Iran. Methods: Patients with probable diagnosis of a...
متن کاملHereditary angioedema: A rare cause of recurrent abdominal pain
Hereditary angioedema is a rare autosomal dominant inherited disease which is characterized by an episodic, self-limiting increase in vascular permeability. Symptoms commonly involve in nonpitting, nonpruritic skin swellings. We present a case of hereditary angioedema. The patinets complained of a recurrent abdominal pain without accompanying skin swelling whose diagnosis was delayed nearly 20 ...
متن کامل165 Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2 Receptor Antagonist in Patients With Hereditary Angioedema due to C1-INH Deficiency
caused by autoantibodies against C1-INH (AAE type II). Reduced C1-INH activity leads to uncontrolled bradykinin formation and to angioedema symptoms. There is no established treatment for AAE. Replacement with plasma-derived C1-INH is effective in most patients with life-threatening attack; however, icatibant, a bradykinin B2 receptor antagonist, may represent an alternative treatment. Methods:...
متن کاملNew treatments addressing the pathophysiology of hereditary angioedema
Hereditary angioedema is a serious medical condition caused by a deficiency of C1-inhibitor. The condition is the result of a defect in the gene controlling the synthesis of C1-inhibitor, which regulates the activity of a number of plasma cascade systems. Although the prevalence of hereditary angioedema is low - between 1:10,000 to 1:50,000 - the condition can result in considerable pain, debil...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of investigational allergology & clinical immunology
دوره 23 7 شماره
صفحات -
تاریخ انتشار 2013